CaliberCos director granted 23,585 stock options
CaliberCos Inc. director Jerome Alan Reid Jr. received a grant of 23,585 employee stock options as part of his compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CaliberCos Inc. director Jerome Alan Reid Jr. received a grant of 23,585 employee stock options as part of his compensation. The options allow him to buy CaliberCos Class A common stock at an exercise price of $0.65 per share and expire on June 30, 2036. All 23,585 options were reported as directly owned following this grant, and there were no open-market purchases or sales in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Options (right to buy) | 23,585 | $0.00 | $0.00 |
Footnotes (2)
- F1. Employee Stock Options (right to buy)("Options") granted pursuant to Issuer's 2024 Equity Incentive Plan. Such Options represent a portion of Reporting Person's compensation as a director of Issuer.
- F2. Not applicable.
Key Figures
Key Terms
Employee Stock Options (right to buy) financial
2024 Equity Incentive Plan financial
Class A Common Stock financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CaliberCos Inc. (CWD) report in this Form 4?
What are the terms of the 23,585 stock options granted at CaliberCos (CWD)?
Was the CaliberCos (CWD) Form 4 transaction an open-market buy or sale?
How many CaliberCos (CWD) derivative securities does the director hold after this grant?
Under which plan were the CaliberCos (CWD) stock options granted?
AI-generated analysis. How Rhea-AI works. Not financial advice.